MLTA3698A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MLTA3698A, covering 2016-11-02 to 2016-11-02. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis [Phase 2]